ConductScience.org, home

Paper7435290

Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid.

Fodstad H and 1 other. Acta Neurochir (Wien), 1980. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid. Papers, record 7435290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7435290

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid.
PubMed
Journal
Acta Neurochir (Wien)
PubMed
Year
1980
PubMed
Publication types
Letter
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2019-08-14
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fodstad HH
2Thulin CAC A

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cyclohexanecarboxylic AcidsMajor topic
Subarachnoid HemorrhageMajor topic
Tranexamic AcidMajor topic
Humans

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114016787Contribution of radiology to the study of intracranial aneurysms.Br Med J1962https://conductscience.org/library/papers/14016787PubMed
25393836AMCA (aminomethyl cyclohexane carboxylic acid, Cyklo-kapron) a potent haemostatic agent in urinary tract bleeding.Scand J Urol Nephrol1969https://conductscience.org/library/papers/5393836PubMed
34684590Fibrinolytic activity of the cerebrospinal fluid after subarachnoid haemorrhage.Acta Neurol Scand1973https://conductscience.org/library/papers/4684590PubMed
45072650Fibrinolysis and subarachnoid haemorrhage. Inhibitory effect of tranexamic acid. A clinical study.Acta Neurol Scand1972https://conductscience.org/library/papers/5072650PubMed
55790480The use of antifibrinolytic substances in ruptured intracranial aneurysms.Neurochirurgia (Stuttg)1969https://conductscience.org/library/papers/5790480PubMed
6356311Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.Surg Neurol1978https://conductscience.org/library/papers/356311PubMed
77376944Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid.Acta Neurochir (Wien)1980https://conductscience.org/library/papers/7376944PubMed
85911370Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations. Based on 6368 cases in the cooperative study.J Neurosurg1966https://conductscience.org/library/papers/5911370PubMed
9505491Tranexamic acid in subarachnoid hemorrhage. A double-blind study.Stroke1979https://conductscience.org/library/papers/505491PubMed
104830928Earlier operation and antifibrinolytic therapy in the management of aneurysmal subarachnoid haemorrhage. Review of recent experience in Tasmania.Med J Aust1974https://conductscience.org/library/papers/4830928PubMed
11346153Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?Br Med J1978https://conductscience.org/library/papers/346153PubMed
12572002Computed tomography in aneurysmal subarachnoid hemorrhage.Neurology1979https://conductscience.org/library/papers/572002PubMed
13517175Spontaneous thrombosis of ruptured intracranial aneurysms during treatment with tranexamic acid (AMCA). Report of three cases.Acta Neurochir (Wien)1979https://conductscience.org/library/papers/517175PubMed
145808181Radioactive albumin microspheres for studies of the pulmonary circulation.Radiology1969https://conductscience.org/library/papers/5808181PubMed
15365072Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.Ann Neurol1977https://conductscience.org/library/papers/365072PubMed
16354483Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.Ann Neurol1978https://conductscience.org/library/papers/354483PubMed
175921326Natural history of subarachnoid hemorrhage, intracranial aneurysms and arteriovenous malformations.J Neurosurg1966https://conductscience.org/library/papers/5921326PubMed
194718188The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage.Acta Neurol Scand1973https://conductscience.org/library/papers/4718188PubMed
20742821The effect of tranexamic acid on the fibrinolytic activity of vein walls.Ann Chir Gynaecol1978https://conductscience.org/library/papers/742821PubMed
21624294Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.Eur Neurol1978https://conductscience.org/library/papers/624294PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7435290

GET https://conductscience.org/api/papers/v1/7435290/authors